NEW YORK (GenomeWeb) – Biodesix said today that it has added $12 million in follow-on financing to a series E round that raised $15 million in 2013 and 2014, bringing total proceeds of the sale to $27 million.

The company said that existing shareholders provided nearly all of the capital for the follow-on sale.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.